Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Allergan
Sort By
Newest First
1 / 2
1 / 2
Licensing
AstraZeneca Completes Recovery of Global Rights to Brazikumab from Allergan
AstraZeneca
PR-M05-20-NI-019
May 14, 2020
FDA Approval
Allergan Receives FDA Approval for Migraine Treatment
Allergan, plc
PR-M01-20-NI-001
Jan 02, 2020
Collaboration
Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders
Allergan, plc
PR-M11-19-NI-013-1960
Nov 14, 2019
M&A
AbbVie Issues Large Bond to Finance Allergan Merger
Nice Insight
PAO-M11-19-NI-006
Nov 12, 2019
Recall
FDA Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from Market
U.S. Food & Drug Administration
PR-M07-19-NI-071
Jul 26, 2019
M&A
AbbVie to Acquire Allergan for $63 Billion
AbbVie
PR-M06-19-NI-052
Jun 25, 2019
FDA Approval
Allergan Announces FDA Approval of AVYCAZ® (ceftazidime and avibactam) for Pediatric Patients
Allergan, plc
PR-M03-19-NI-054
Mar 20, 2019
Data
Allergan Presents Data From Seven Abstracts At The 2019 American Academy of Dermatology (AAD) in Washington D.C.
Allergan, plc
PR-M03-19-NI-004
Mar 01, 2019
Biosimilar
Amgen And Allergan Announce Positive Top-Line Results From Phase 1/ Phase 3 Study Of ABP 798, Biosimilar Candidate To Rituximab
Amgen
PR-M01-19-NI-079
Jan 28, 2019
R&D
Allergan Establishes R&D Group in Massachusetts
Nice Insight
PAO-M01-19-NI-010
Jan 09, 2019
FDA Approval
Allergan Bags Another Body Contouring Approval
Nice Insight
PAO-M10-18-NI-023
Oct 22, 2018
Clinical Study
Allergan Launches Personalized Study Approach for Clinical Research Programs in Inflammatory Bowel Disease
Allergan, plc
PR-M10-18-NI-024
Oct 08, 2018
Acquisition
Allergan Makes Neurotoxin Buy with Acquisition of Bonti Inc.
Emilie Branch
Pharma's Almanac
PAO-M09-18-NI-015
Sep 19, 2018
Appointment
Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process
Allergan, plc
PR-M08-18-NI-096
Aug 22, 2018
Fast Track
Allergan Receives FDA Fast Track Designation for AGN-241751 for the Treatment of Major Depressive Disorder (MDD)
Allergan, plc
PR-M07-18-NI-080
Jul 24, 2018
Announcement
Science Exchange Adds Allergan EVP & Chief R&D Officer David Nicholson to Its Board of Directors
Science Exchange
PR-M06-18-NI-099
Jun 29, 2018
Clinical Data
Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant
Allergan, plc
PR-M06-18-NI-051
Jun 14, 2018
Drug Delivery
Allergan Announces Launch of the TrueTear® Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting
Allergan, plc
PR-M04-18-NI-55
Apr 17, 2018
Results
Allergan and Richter Announce Positive Topline Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression
Allergan, plc
PR-M04-18-NI-018
Apr 05, 2018
Earnings
Allergan to Report First Quarter 2018 Earnings and Host Conference Call and Webcast
Allergan, plc
PR-M04-18-NI-012
Apr 04, 2018
